291 related articles for article (PubMed ID: 26776286)
21. Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations.
Mory PB; Crispim F; Freire MB; Salles JE; Valério CM; Godoy-Matos AF; Dib SA; Moisés RS
Eur J Endocrinol; 2012 Sep; 167(3):423-31. PubMed ID: 22700598
[TBL] [Abstract][Full Text] [Related]
22. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism.
Hegele RA; Joy TR; Al-Attar SA; Rutt BK
J Lipid Res; 2007 Jul; 48(7):1433-44. PubMed ID: 17374881
[TBL] [Abstract][Full Text] [Related]
23. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations.
Mori E; Fujikura J; Noguchi M; Nakao K; Matsubara M; Sone M; Taura D; Kusakabe T; Ebihara K; Tanaka T; Hosoda K; Takahashi K; Asaka I; Inagaki N; Nakao K
Metabolism; 2016 Apr; 65(4):543-56. PubMed ID: 26975546
[TBL] [Abstract][Full Text] [Related]
24. Lipodystrophies.
Garg A
Am J Med; 2000 Feb; 108(2):143-52. PubMed ID: 11126308
[TBL] [Abstract][Full Text] [Related]
25. Central players in inherited lipodystrophies.
Jeninga EH; Kalkhoven E
Trends Endocrinol Metab; 2010 Oct; 21(10):581-8. PubMed ID: 20621503
[TBL] [Abstract][Full Text] [Related]
26. Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study.
Akinci G; Topaloglu H; Demir T; Danyeli AE; Talim B; Keskin FE; Kadioglu P; Talip E; Altay C; Yaylali GF; Bilen H; Nur B; Demir L; Onay H; Akinci B
Neuromuscul Disord; 2017 Oct; 27(10):923-930. PubMed ID: 28754454
[TBL] [Abstract][Full Text] [Related]
27. A-type lamin-linked lipodystrophies.
Vigouroux C; Capeau J
Novartis Found Symp; 2005; 264():166-77; discussion 177-82, 227-30. PubMed ID: 15773753
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of a short human seipin/BSCL2 isoform in mouse adipose tissue results in mild lipodystrophy.
Cui X; Wang Y; Meng L; Fei W; Deng J; Xu G; Peng X; Ju S; Zhang L; Liu G; Zhao L; Yang H
Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E705-13. PubMed ID: 22234369
[TBL] [Abstract][Full Text] [Related]
29. A study of congenital generalized lipodystrophy (CGL) caused by BSCL2 gene mutation.
Ye JY; Huang AJ; Fu ZZ; Gong YY; Yang HY; Zhou HW
Yi Chuan; 2022 Oct; 44(10):926-936. PubMed ID: 36384728
[TBL] [Abstract][Full Text] [Related]
30. How to diagnose a lipodystrophy syndrome.
Vantyghem MC; Balavoine AS; Douillard C; Defrance F; Dieudonne L; Mouton F; Lemaire C; Bertrand-Escouflaire N; Bourdelle-Hego MF; Devemy F; Evrard A; Gheerbrand D; Girardot C; Gumuche S; Hober C; Topolinski H; Lamblin B; Mycinski B; Ryndak A; Karrouz W; Duvivier E; Merlen E; Cortet C; Weill J; Lacroix D; Wémeau JL
Ann Endocrinol (Paris); 2012 Jun; 73(3):170-89. PubMed ID: 22748602
[TBL] [Abstract][Full Text] [Related]
31. Lipodystrophies-Disorders of the Fatty Tissue.
Knebel B; Müller-Wieland D; Kotzka J
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233602
[TBL] [Abstract][Full Text] [Related]
32. Congenital generalized lipodystrophies--new insights into metabolic dysfunction.
Patni N; Garg A
Nat Rev Endocrinol; 2015 Sep; 11(9):522-34. PubMed ID: 26239609
[TBL] [Abstract][Full Text] [Related]
33. Congenital lipodystrophies and dyslipidemias.
Prieur X; Le May C; Magré J; Cariou B
Curr Atheroscler Rep; 2014 Sep; 16(9):437. PubMed ID: 25047893
[TBL] [Abstract][Full Text] [Related]
34. Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome).
Owen KR; Donohoe M; Ellard S; Clarke TJ; Nicholls AJ; Hattersley AT; Bingham C
Nephron Clin Pract; 2004; 96(2):c35-8. PubMed ID: 14988595
[TBL] [Abstract][Full Text] [Related]
35. Lipodystrophy: beyond generalization?
Freitas P; Carvalho D
Panminerva Med; 2013 Sep; 55(3):253-68. PubMed ID: 24088799
[TBL] [Abstract][Full Text] [Related]
36. Gene-gene and gene-environment interactions in lipodystrophy: Lessons learned from natural PPARγ mutants.
Broekema MF; Savage DB; Monajemi H; Kalkhoven E
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May; 1864(5):715-732. PubMed ID: 30742913
[TBL] [Abstract][Full Text] [Related]
37. A new laminopathy caused by an Arg133/Leu mutation in
Wang Z; Dong Y; Yang J; He Y; Lin X; Wu F; Li H; Zheng F
Adipocyte; 2019 Dec; 8(1):280-291. PubMed ID: 31293201
[TBL] [Abstract][Full Text] [Related]
38. Type 2 congenital generalized lipodystrophy with a heterozygous missense NOTCH2 mutation.
Wang M; Cun Z; Peng J; Chen R; Li J
Eur J Clin Nutr; 2022 Jul; 76(7):1041-1043. PubMed ID: 35043011
[TBL] [Abstract][Full Text] [Related]
39. Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy.
Boutet E; El Mourabit H; Prot M; Nemani M; Khallouf E; Colard O; Maurice M; Durand-Schneider AM; Chrétien Y; Grès S; Wolf C; Saulnier-Blache JS; Capeau J; Magré J
Biochimie; 2009 Jun; 91(6):796-803. PubMed ID: 19278620
[TBL] [Abstract][Full Text] [Related]
40. LMNA-linked lipodystrophies: from altered fat distribution to cellular alterations.
Bidault G; Vatier C; Capeau J; Vigouroux C; Béréziat V
Biochem Soc Trans; 2011 Dec; 39(6):1752-7. PubMed ID: 22103520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
